The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
“The IHE is delighted to welcome Rob Seidel as Board Chair,” said Dr. McCabe, the IHE’s CEO and Executive Director. “Rob Seidel’s extensive experience in board governance and in leading health-related organizations such as Alberta Innovates – Health Solutions has clearly demonstrated his significant expertise and commitment to developing successful partnerships and collaborations…
The specific policy outlined in this document relates directly to Board members of the Institute of Health Economics in performing their governance role.
This Privacy Statement of the Institute of Health Economics (IHE), 1200 – 10405 Jasper Avenue NW, Edmonton, Alberta T5J 3N4 ("IHE" "we" "us" or "our") outlines how your personally identifiable information and other data relating to you (your "personal data") will be collected, used, and shared in connection with your access to and/or use of IHE.ca, and affiliated sites NOAHE.ca…
The IHE Policy Surrounding Political Activity outlines the expectation of the Institute of Health Economics (IHE) for staff surrounding political activity.
The Institute of Health Economics (IHE) and Applied Pharmaceutical Innovation (API) are creating value through collaboration. The IHE and API have signed a Memorandum of Understanding (MOU) in the field of economic analysis and health technology assessment to support each other’s aspiration in the development of a broader, stronger, and more vibrant innovation ecosystem. “Successful…
| Dat Tran, Ilke Akpinar, Irvin Mayers, Tatiana Makhinova, Philip Jacobs
The objective of this study, published in the International Journal of Chronic Obstructive Pulmonary Disease, was to describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada.
L'IHE, le Centre de recherche de l'Institut universitaire en santé mentale de Montréal et l'Université de Montréal ont le plaisir d'annoncer la publication de IHE SÉSaMe 2019 – un manuel virtuel de statistiques économiques sur la santé mentale qui résume les données les plus récentes disponibles concernant les indicateurs ayant une incidence sur les divers aspects économiques du…
The IHE, the Centre de recherche de l’Institut universitaire en santé mentale de Montréal, and the Université de Montréal are pleased to announce the release of IHE Mental Health In Your Pocket 2019 – a virtual handbook of mental health economic statistics that synthesizes the most current, available data on indicators that affect the various economic aspects of the Canadian mental…
IHE Mental Health In Your Pocket 2019 is a pan-Canadian virtual handbook of mental health economic statistics, developed in partnership with the Centre de recherche de l’Institut universitaire en santé mentale de Montréal and Montréal University, which synthesizes a large amount of the most currently available data into indicators on the various economic aspects of the mental health…
IHE SÉSaMe 2019 est un recueil virtuel pancanadien de statistiques économiques sur la santé mentale, élaboré en partenariat avec le Centre de recherche de l'Institut universitaire en santé mentale de Montréal et l'Université de Montréal, qui synthétise une grande partie des données actuellement disponibles en indicateurs sur les divers aspects économiques du système de santé mentale.…
L’IHE dans votre poche 2017 – Guide de statistiques sur l’économie de la santé September 19, 2017 L’IHE dans votre poche 2017 – Guide de statistiques sur l’économie de la santé présente et divise les données les plus récentes en sections portant sur le fardeau économique de la maladie, les ressources en soins de santé, les comportements liés à la santé, l'état de santé, les données…
IHE Mental Health In Your Pocket 2019 is a compendium of economic statistics about mental health in Canada; it brings together information that demonstrates the burden of mental illness and where Canada’s mental health system ranks among other developed countries. To provide important consolidated information on key indicators that depict the state of our mental health system,…
IHE Statistiques économiques en santé mentale dans votre poche (SÉSaMe) 2019 est un recueil de statistiques économiques sur la santé mentale au Canada. Il rassemble des informations qui démontrent le fardeau que représentent les maladies mentales et indiquent la position relative du système de santé mentale canadien…
08:00 – 08:15 Opening Remarks John Sproule, Senior Policy Director, IHE 08:15 – 09:15 Implementation science: If it's not knowledge translation, and not change management, what is it?Dr. Carl May, Professor, Medical Sociology, London School of Hygiene & Tropical Medicine Download Presentationhttps://vimeo.com/357889527 09:15 – 09:30 Audience Questions 09:25 – 09:30 Closing Remarks…
PDF of a PowerPoint presentation by Dr. Carl May, Professor of Medical Sociology at the London School of Hygiene and Tropical Medicine.
Implementation Science Breakfast Plenary
The IHE is pleased to have partnered with Abbott and other global health industry leaders to launch the UNIVANTS of Healthcare Excellence award. This annual award honours integrated, multidisciplinary clinical care teams with innovative approaches to achieve measurably better healthcare performance for patients, clinicians, payers, and healthcare institutions. The UNIVANTS of Healthcare…
The IHE was founded on the belief that the best solutions to healthcare problems will be found through collaboration, with all stakeholders at the table sharing expertise, insights, and experiences. The Institute is committed to acting as critical friend, trusted partner, and neutral broker to engage the public, private, and academic sectors to help solve some of the complex challenges…
| Charles Yan, Katherine Rittenbach, Sepideh Souri, Peter H. Silverstone
This analysis, published in BMC Psychiatry, aimed to determine cost-effectiveness of a stepped-care pathway for depression in adults in primary care versus standard care (SC), treatment-as-usual (TAU), and online cognitive behavioural therapy (CBT).
| Samuel N. Frempong, Andrew J. Sutton, Clare Davenport, Pelham Barton
The aim of this study, published in PharmacoEconomics – Open, was to conduct an early economic analysis of a hypothetical rapid test for typhoid fever diagnosis in Ghana and identify the necessary characteristics of the test for it to be cost effective in Ghana.
The IHE is delighted to have provided support to CASA for the very popular and well-attended Dr. Roger Bland Community Lecture Series. This mini-series addressed important issues in children’s mental health, with each event featuring a keynote speaker and an expert panel to lead the conversation and answer audience questions. Each of these free events welcomed everyone to attend…
This study, published in PharmacoEconomics – Open, reports exploratory analysis of the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. The costs of industry-sponsored drug CTs completed in 2016 were Can$2.1 billion. In addition to the creation of knowledge, these trials play an important role in alleviating the healthcare cost burden…
| Dat Tran, Thanh Nguyen, Arto Ohinmaa, Irvin Mayers, Philip Jacobs
OBJECTIVES: To examine the resource use and healthcare costs for chronic obstructive pulmonary disease (COPD) in Alberta, Canada between 2008 and 2016 and model the future costs to 2030.
Clinical research is funded by industry, governments, charities, and hospitals. It is important to know the economic commitment of the various funding bodies, but until now there has been no national source available which provides these data. We surveyed the major funders to provide such a measure. There is evidence that government and charity funding of medical research is a…
The IHE can provide health economics-related insights and research to support the decision-making of any and all health system stakeholder groups. For more information, please contact us at (780) 448 4881, or by email at [email protected]. Examples of Past Collaborations Metabolomic Technologies Inc. Alberta to begin assessing a new colorectal cancer screening strategy using Metabolomic…
Economic analysis, especially in reflection of the current funding climate, has become a critical way to describe the cost-effectiveness, cost-benefit, and/or cost-efficiency of new innovations, and contributes to the value propositions for real-world application. Including an applied health economics research component in grant applications can increase your likelihood of grant…
Be Confident in Your Decisions Changing how Alberta pays for health care is critical to improve value, achieve better quality, and slow cost growth. There is a need in Alberta for greater capacity in applied economics knowledge that both enhances economic surveillance that is independent from government, and supports ongoing provincial development of organizational and incentive…
In this photo (from left): Dr. Arto Ohinmaa (University of Alberta), Dr. Mike Paulden (University of Alberta), Ryan Au (Award Winner), Ryan Fung (Award Winner), Julia Dabravolskaj (Award Winner), Carla Ickert (Award Winner), Dr. Christopher McCabe (IHE) The IHE is delighted to congratulate Ryan Au, Julia Dabravolskaj, Ryan Fung, and Carla Ickert of the University of Alberta as…
In this photo (from left): Dr. Mingshan Lu (University of Calgary), Dr. Christopher McCabe (IHE), Eashita Dabas (Award Winner), Kolawole Adedapo (Award Winner), Melanie Varkey (Award Winner), Dr. Jeff Round (IHE). Missing (inset): Anuj Sharma (Award Winner) The IHE is delighted to congratulate Kolawole Adedapo, Eashita Dabas, Anuj Sharma, and Melanie Varkey of the University of…
| Helena M Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi, Karen McAdam, Luke Hughes-Davies, Adrian N Harnett, Mei-Lin Ah-See, Richard Simcock, Daniel Rea, Sanjay Raj, Pamela Woodings, Mark Harries, Donna Howe, Kerry Raynes, Helen B Higgins, Maggie Wilcox, Chris Plummer, Janine Mansi, Ioannis Gounaris, Betania Mahler–Araujo, Elena Provenzano, Anita Chhabra, Jean E Abraham, Carlos Caldas, Peter S Hall, Christopher McCabe, Claire Hulme, David Miles, Andrew M Wardley, David A Cameron
Adjuvant trastuzumab significantly improves outcomes for patients with HER2-positive early breast cancer. The standard treatment duration is 12 months but shorter treatment could provide similar efficacy while reducing toxicities and cost. We aimed to investigate whether 6-month adjuvant trastuzumab treatment is non-inferior to the standard 12-month treatment regarding disease-free…
| Michelle Pollock, Ann Scott, Jennifer Seida, Paula Corabian, Andrew J. Sutton, Mike Paulden, Christopher McCabe, Lisa Tjosvold, Bing Guo
The clinical review and economic evaluation aimed to determine how Oncotype DX and Prosigna can be optimally used to determine which patients with early-stage breast cancer will benefit from adjuvant chemotherapy. This report addresses the following research question: For patients with early-stage (I–III), ER+, HER2?, node-negative or node-positive (one to three nodes) breast…
12:20 – 12:30 Opening RemarksKen Bond, Director of HTA and External Relationships, IHE 12:30 – 13:15 Big questions about big data: Social and ethical implications of using real-world data in the public and private sectorsProf Annette Braunack-Mayer, Head, School of Health and Society, University of Wollongong, AustraliaDownload Presentation 13:15 – 13:25 Audience Questions 13:25…
Biographies Prof Annette Braunack-Mayer Prof Braunack-Mayer is a bioethicist and public health researcher. Her research combines ethical analysis with a wide range of qualitative methods for engaging with citizens, patients, consumers and stakeholders. She has particular expertise in the use of deliberative methods of engagement with communities, but her research skill set extends…
29 May 2019 Edmonton, Alberta On May 29, 2019, the Institute of Health Economics (IHE), the Network of Alberta Health Economists (NOAHE) and the Alberta Real World Evidence Consortium (Alberta RWE) were delighted to host Prof Annette Braunack-Mayer of the University of Wollongong, Australia, who discussed the social and ethical issues related to the collection and use of real world…
PDF of a PowerPoint presentation by Prof Braunack-Mayer, Head, School of Health and Society, University of Wollongong, Australia.
Big Questions about Big Data Event
| Timothy Caulfield, Alessandro R Marcon, Blake Murdoch, Jasmine Brown, Sarah Tinker Perrault, Jonathan Jarry, Jeremy Snyder, Samantha J Anthony, Stephanie Brooks, Zubin Master, Christen Rachul, Ubaka Ogbogu, Joshua Greenberg, Amy Zarzeczny, Robyn Hyde-Lay
Abstract: Numerous social, economic and academic pressures can have a negative impact on representations of biomedical research. We review several of the forces playing an increasingly pernicious role in how health and science information is interpreted, shared and used, drawing discussions towards the role of narrative. In turn, we explore how aspects of narrative are used in…
Due to positive response to the IHE’s Health Economics Educational Workshop held in Calgary and Edmonton in November 2018, the IHE is now offering an online edition – the IHE Health Economics Virtual Workshop. The IHE Health Economics Virtual Workshop is a free, online workshop for small- and medium-sized life science companies. This online course is designed to help participants…
Learn how health economics and early-stage technology assessment can support your research and development planning, raise capital, and help communicate your value proposition more clearly and effectively to payers. The IHE provides Alberta small- and medium-sized enterprises (SMEs) and innovation ecosystem partners with educational services to describe the importance of, and requirements…
Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service. The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present…
What are the prerequisites? Although this course was developed for a life science audience, it is open to anyone interested. There are no prerequisites required to take this course. Who is providing this course? The Institute of Health Economics developed this course and its content material. Who teaches the content? The course is taught by Health Economists from the Institute…
The IHE’s Small- and Medium-Sized Enterprise (SME) Commercialization Platform is pleased to present the IHE Health Economics Virtual Workshop – a free, online course where you can learn more about how health economics and early-stage technology assessment can support research and development planning, support with raising capital, and help communicate technology value proposition…
| Dat Tran, Thanh Nguyen, Dawn Opgenorth, Xiaoming Wang, Danny Zuege, David A. Zygun, Henry T. Stelfox, Sean M. Bagshaw
This study, published in the Journal of Critical Care, explores the association between strained ICU capacity and healthcare costs, and demonstrates the admissions to ICUs experiencing strain incur incremental costs, attributed to longer hospitalization and physician services.
| Paula Corabian, Bing Guo, Carmen Moga, Ann Scott
This article retrospectively examines the evolution of rapid assessments (RAs) produced by the Health Technology Assessment (HTA) Program at the Institute of Health Economics over its 25-year relationship with a single requester, the Alberta Health Ministry (AHM).
| Paula Corabian, Bing Guo, Carmen Moga, Ann Scott
The Health Technology Assessment Program at the Institute of Health Economics has conducted rapid assessments (RAs) since 1993. This information paper draws on this experience and describes the evolution of RA process and products over a 25-year relationship with a single requester to quantify the effects of this partnership on the RAs produced. The aim is to contribute to emergent…
| Nancy Zuck, John Sproule, Charles Cook, Rebecca Albrecht
Alberta Health initiated the Nurse Practitioner Demonstration Project(s) (NPDP) in 2016 to support access to and further integration of Nurse Practitioners (NPs) into Alberta’s primary health care system. Funding was provided (based on diverse program plans) to the Boyle McCauley Health Centre (BMHC), The Alex Community Health Centre (The Alex), the Calgary Urban Project…
Ce rapport fournit un résumé d’un atelier de sprint sur la conception de données probantes du monde réel (DPMR) qui a eu lieu le 21 octobre 2018 à Toronto, en Ontario. L’atelier a été conçu et offert dans le cadre d’un partenariat entre l’Agence canadienne des médicaments et des technologies…
| Angus Thompson, Maria Ospina, Liz Dennett, Arianna Waye, Philip Jacobs
Presenteeism, reduced productivity while working, has come into consideration as a major occupational health problem in many countries with serious consequences for both organizations and employees. Increasing evidence shows that presenteeism represents a significant source of productivity losses that can cost organizations much more than does absenteeism, and it can lead to an…
This report is from an Alberta Strategic Clinical Networks (SCN) exchange meeting with Mr. Neil Fraser. This event brought together SCNs and related health system stakeholders, and a leader in the Canadian medical technology industry, and recent member of a Federal Advisory Panel on Healthcare Innovation. The meeting had the objectives to help the SCNs to understand the Advisory…
Background: Significant gaps in the evidence base on costs in rural communities in Canada and elsewhere are reported in the literature, particularly regarding costs to families. However, it remains unclear whether the costs related to all resources used by palliative care patients in rural areas differ to those resources used in urban areas.
19 November 2015Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://vimeo.com/channels/907291/147158286 Keynote presentations Horizontal Integration to Improve Youth Mental Health Care In Canada Dr. Stan Kutcher, ONS, MD, FRCPC, FCAHS, Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University…
Speaker Biographies Keynote Speakers Dr. Stan Kutcher, ONS, MD, FRCPC, FCAHSSun Life Financial Chair in Adolescent Mental Health and Director World Health Organization Collaborating Center in Mental Health Policy and Training, Dalhousie University and IWK Health Centre Dr. Kutcher is an internationally-renowned expert in adolescent mental health and an international leader in mental…
19 November 2015 Edmonton, Alberta Strengthening Mental Health Services for Children and Families is the 14th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XIV – Strengthening Mental Health Services for Children and Families…
Strengthening Mental Health Services for Children and Families is the 14th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Stan Kutcher, ONS, MD, FRCPC, FCAHS, Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University and IWK Health Centre.
IHE Innovation Forum XIV – Strengthening Mental Health Services for Children and Families
The Institute of Health Economics held a roundtable on June 4, 2015, entitled Innovative Funding Models: Kidney Care Policy Options for the Future, to identify and discuss key issues in kidney care policy options. Prior to the roundtable, an Innovative Funding Models: Kidney Care Policy Options for the Future Steering Committee teleconference refined project objectives, and the…
Thursday, 5 November 2015 Niagara Falls, Ontario Welcome and Greetings Jasmine BrownSenior Policy Associate, IHEhttp://vimeo.com/album/3671742/video/146488852 Topic 1: Overview of the Need for Integrated Systems Dr. Irvin MayersProfessor, Division of Pulmonary Medicine, University of Alberta;Chair of the COPD Policy Framework Study Expert Advisory CommitteeDownload Presentationhttp://vimeo.com/album/3671742/video/146488854…
5 November 2015 Niagara Falls, Ontario Clinicians and policy makers from across Canada gathered at this workshop to present the latest evidence and best practices of Chronic Obstructive Pulmonary Disease (COPD) care in Canada, as part of the broader effort to develop policy recommendations, applicable to jurisdictions across Canada, that will lead to a better coordinated, more…
Workshop Final Report Bringing about change in COPD care – White paperDownload Summary Report Program Chronic Obstructive Pulmonary Disease (COPD) Economic Issues Policy Workshop – Final ProgramDownload Final Program Related Report Economic Surveillance for Chronic Obstructive Pulmonary Disease (COPD) in AlbertaDownload Related Report Related Report Infographic IHE…
Speaker Biographies | Steering Committee Speaker Biographies Dr. Cathy Clelland, MD Head of Department of Family Practice, Royal Columbian Hospital Consultant, General Practitioners Services Committee, British Columbia Cathy Clelland obtained medical training at the University of Alberta and her Family Medicine residency at the Misericordia Hospital in Edmonton. She practiced full…
The purpose of this workshop was to examine COPD management in Canada through presentation of analyses and examples of system supports to action best practices to a select group of clinical leaders and relevant public sector decision makers. The group deliberated, and key themes and policy recommendations from discusssion were captured to form the basis of the final COPD Policy…
PDF of a PowerPoint presentation by Dr. Irvin Mayers, Professor, Division of Pulmonary Medicine, University of Alberta; Chair of the COPD Policy Framework Study Expert Advisory Committee.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Arianna Waye, Health Economist, Institute of Health Economics.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Mr. Michael G. Stewart, Director, Clinical Support Branch, Ontario Ministry of Health and Long-Term Care.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Michael Stickland, Associate Professor, Division of Pulmonary Medicine, University of Alberta; Heart & Stroke Foundation New Investigator.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Simon Lessard, Quebec Lung Association Board & Scientific Committee Member, Community Pharmacist.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Cathy Clelland, Head of Department of Family Practice, Royal Columbian Hospital; Consultant, General Practitioners Services Committee, British Columbia.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Mr. Stephen Samis, Vice President, Programs, Canadian Foundation for Healthcare Improvement; and Dr. Graeme Rocker, Professor of Medicine, Dalhousie University; Faculty, Canadian Foundation for Healthcare Improvement.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
The Institute of Health Economics (IHE), in partnership with Boehringer Ingelheim (Canada) Ltd./Ltée held an invitational forum on October 3, 2015, in Edmonton, Alberta. The purpose of this discussion was to bring together multiple stakeholders from across Canada to investigate the current state of evidence and information regarding idiopathic pulmonary fibrosis (IPF) and…
3 October 2015 Edmonton, Alberta The purpose of this discussion was to bring together multiple stakeholders from across Canada to investigate the current state of evidence and information regarding idiopathic pulmonary fibrosis (IPF) and provide recommendations regarding special considerations for policy making and healthcare decision-making. The draft recommendations will be used…
Objective: In this study, we estimate the impact of the new PCV13 immunization program on the burden of disease and related healthcare costs in Alberta.
OBJECTIVES: To examine differences in health services utilization (HSU) costs in the first year of life between low birth weight (LBW) and normal birth weight (NBW) infants, identify maternal and child characteristics associated with HSU costs, and estimate annual HSU cost of LBW infants for the province of Alberta, Canada.
| Bing Guo, Carmen Moga, Christa Harstall, Don Schopflocher
Objective: Because of a lack of a control group, a case-series study is considered one of the weaker study designs from which to obtain evidence on treatment effectiveness. Under certain circumstances, however, this is the only available evidence to inform health-care decisions. This study's intent was to develop and validate a quality appraisal checklist specifically for…
"General Inquiries" provides IHE business hours, contact information, and mailing address.
To subscribe to an IHE mailing list, please click "Subscriptions" below. To unsubscribe from our mailing list at any time, please contact us at [email protected].
General Inquiries
Subscriptions
| Werner J Becker, Ted Findlay, Carmen Moga, Ann Scott, Christa Harstall, Paul Taenzer
Objective: To increase the use of evidence-informed approaches to diagnosis, investigation, and treatment of headache for patients in primary care.
Note: This is an Alberta Ambassador Guideline Adaptation Program related publication.
CIHI/IHE Diagnostic Imaging Invitational Workshop 6 – 7 February 2012 In February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly undertake with its data…
Alberta Health Services (AHS) has recently established a number of Strategic Clinical Networks (SCNs) in the province around specific health care topics (e.g., Cardiovascular Health & Stroke) and within areas where care is delivered (e.g., Surgery). The SCNs are the engines of innovation in the health system and have a mandate to find new and innovative ways of delivering care…
| Don Husereau, Larry Arshoff, Shahira Bhimani, Nicola Allen
This document describes the entry of new medical devices into the Canadian health system. It is intended to provide an accurate description of new medical device entry in Canada, and is intended to give patients, the public, private and public sector health system researchers, medical device companies, and private and public coverage bodies a general understanding of what regulatory,…
Written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an assessment of how the adoption of fFN testing in Alberta impacted the clinical management of preterm labour and healty system resources. This was also an opportunity to retroactively use the Post Policy Implementation Framework to evaluate a specific policy developed within…
24 June 2015 Edmonton, Alberta This SCN/Industry Introduction Day was the first to bring together the SCNs and MEDEC and several of its member companies in the spirit of collaboration and cooperation in order to jointly identify key opportunities to create a mutually productive relationship in support of the work of the SCNs, as well as identify key barriers, issues, and challenges…
Summary Report Partnering for Health System Innovation in Alberta – Summary ReportDownload Report The summary report was prepared by the Institute of Health Economics on behalf of the partners. Key Resources Ernst and Young. Pulse of the Industry: Medical Technology Report 2013.http://www.ey.com/US/en/Industries/Life-Sciences/Pulse-of-the-industry---medical-technology-report-2013…
24 June 2015 Edmonton, Alberta Download Compilation File Of All Presentations (10 MB) Opening Remarks Dr. Pamela Valentine, Interim CEO, Alberta Innovates – Health Solutions Brian Lewis, CEO, MEDEC Keynote Speaker Medical Device Industry's Perspective on the Adoption of Innovation in CanadaNeil Fraser, President & GM, Medtronic Canada, Incoming Chair of MEDECDownload…
PDF of a PowerPoint presentation by Mr. Neil Fraser, President & GM, Medtronic Canada, Incoming Chair of MEDEC.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
PDF of a PowerPoint presentation by Dr. Blair O'Neill, Associate Chief Medical Officer, SCNs.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
PDF of a PowerPoint presentation by Mr. Jitendra Prasad, Chief Program Officer, Contracting, Procurement & Supply Management, AHS.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
We reviewed literature to estimate the costs of Fetal Alcohol Spectrum Disorder (FASD) in the Canadian Criminal Justice System (CJS), and to update the total costs of FASD in Canada. The results suggest FASD is costlier than previous estimates. The costs of FASD associated with the CJS are estimated at $3.9 billion a year, with $1.2 billion for police, $0.4 billion for court,…
4 June 2015 Edmonton, Alberta The Institute of Health Economics held a roundtable on June 4, 2015, entitled Innovative Funding Models: Kidney Care Policy Options for the Future, to identify and discuss key issues in kidney care policy options. Prior to the roundtable, an Innovative Funding Models: Kidney Care Policy Options for the Future Steering Committee teleconference refined…
| Ann Scott, Dion Pasichnyk, Christa Harstall, Dagmara Chojecki
This Information Paper is an inventory and broad summary of factors affecting the adoption and diffusion of health technologies and of available models, strategies, tools, and processes for optimizing health technology diffusion.
| Julie Polisena, John Lavis, Don Juzwishin, Pam McLean-Veysey, Ian Graham, Christa Harstall, Janet Martin
A perceived gap exists in how well Canadian health technology assessment (HTA) producers are supporting the use of their HTAs by decision-makers. The authors propose that the newly released HTA Database Canadian search interface incorporate structured decision-relevant summaries of HTAs that would be developed by participating Canadian HTA organizations. The registry would…
Speaker Biographies Keynote Speakers Dr. Andrew Bjerring Chair, The Expert Panel on Timely Access to Health and Social Data for Health Research and Health System Innovation, Council of Canadian Academies Andrew Bjerring was a founding member of the Board of CANARIE Inc. and was President and CEO for 15 years prior to his retirement in October, 2008. Over the past 25 years, Mr.…
26 May 2015Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://vimeo.com/channels/907291/129602703 Keynote presentations Better Information - Better Health: Accessing Health and Health-Related Data in AlbertaDr. Andrew Bjerring, Council of Canadian Academieshttp://vimeo.com/channels/907291/129280105Download…
26 May 2015 Edmonton, Alberta Better Information - Better Health: Accessing Health and Health-Related Data in Alberta is the 13th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XIII – Better Information - Better Health: Accessing…
NOAHE Evidence Into Practice Luncheon Series II 11 January 2018 - 11 July 2018 The Network of Alberta Health Economists (NOAHE), in partnership with the Institute of Health Economics (IHE), and Alberta Health, is delighted to co-host the 2nd invitational luncheon series, which provides an applied orientation to health economic evaluation. More specifically, the objective of this…
| Braden Manns, Anderson Chuck, Eddy Nason, Lianne Barnieh, John Sproule, Jasmine Brown
This work, conducted by the Institute for Health Economics (IHE) and the University of Calgary (Health Economics group), was performed to better understand the unmet educational needs and health economics products that could support people in the province, and to determine the current capacity for conducting health economics in Alberta. This paper seeks to understand the needs…
Better Information - Better Health: Accessing Health and Health-Related Data in Alberta is the 13th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Andrew Bjerring, Council of Canadian Academies.
IHE Innovation Forum XIII – Better Information - Better Health: Accessing Health and Health-Related Data in Alberta
PDF of a PowerPoint presentation by Mr. William Falk, Rotman School of Management, University of Toronto.
IHE Innovation Forum XIII – Better Information - Better Health: Accessing Health and Health-Related Data in Alberta
Objectives: Economic evaluations, although not formally used in purchasing decisions for medical devices in Canada, are still being conducted and published. The aim of this study was to examine the way that prices have been included in Canadian economic evaluations of medical devices.
Economic surveillance and economic assessments are important sources of information to help administrators and policy makers to track current trends and evaluate policies and care patterns. The Institute of Health Economics, in partnership with Alberta Health, held a two-day Costing Methods Workshop which helped to review costing practices by bringing together economists and other…
| Deborah Marshall, Egon Jonsson, Liam Martin, Diane Mosher, Karen V. MacDonald
This White Paper discusses the concept of developing a comprehensive rheumatoid arthritis registry in Alberta, and the important health, social, and economic gains such a resource would generate for Alberta.
The Federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which could help Canada reduce growth…
17 February 2015 Toronto, Ontario The Federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which…
Summary Report Industry/Government Collaboration in Healthcare Innovation Roundtable – Summary ReportDownload Report Background Document Industry/Government Collaboration in Healthcare Innovation Roundtable – Background DocumentDownload Background Document Final Report of the Advisory Panel on Healthcare Innovation available on the Government of Canada webpage Report…
This book includes the plenary presentations made at the first international conference on prevention of FASD, which was attended by about 700 people from 35 countries around the globe. The issues addressed are FASD as a priority in health policy making; its prevalence and incidence; strategies for prevention; current applied and basic research in the field; the role of the medical…
Fetal alcohol spectrum disorder (FASD) is of growing concern around the world. A range of disabilities caused by prenatal exposure to alcohol, FASD is estimated to affect 2% to 5% of all newborns in the industrialized countries of Europe and North America, and the rates may be significantly higher in some developing countries and certain defined populations. Epidemiological studies…
The federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which could help Canada reduce growth…
Our Areas of Expertise The IHE can carry out projects in any of our areas of expertise for public and private funders and partners. Please contact us to see if we can help with any project in support of evidence-informed health care policy and practice at [email protected]. Health Technology Assessment The IHE’s HTA Unit conducts a comprehensive range of high-quality, relevant, and timely…
| Maria Ospina, Liz Dennett, Arianna Waye, Philip Jacobs, Angus Thompson
Objectives: To assess and compare the measurement properties (ie, validity, reliability, responsiveness) and the quality of the evidence of presenteeism instruments.
Listed in reverse chronological order. Guideline for primary care management of headache in adults. Becker WJ, Findlay T, Moga C, Scott A, Harstall C, Taenzer P. Guideline for primary care management of headache in adults. Canadian Family Physician. 2015 Aug;61(8):670-679 PMID: 26505063 Adapting low back pain guidelines within a multidisciplinary context: a process evaluation.…
| Thanh Nguyen, Egon Jonsson, Jessica Moffatt, Liz Dennett, Anderson Chuck, Shelley Birchard
Abstract: Parent-Child Assistance Program (P-CAP) is a 3-year home visitation/harm reduction intervention to prevent alcohol exposed births, thereby births with fetal alcohol spectrum disorder, among high-risk women. This article used a decision analytic modelling technique to estimate the incremental cost-effectiveness ratio and the net monetary benefit of the P-CAP…
PDF of a PowerPoint Presentation by Dr. Siok Swan Tan, Erasmus University, institute for Medical Technology Assessment (iMTA).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mrs. Lesley Curtis, Personal Social Services Research Unit (PSSRU), UK.
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Dr. Unto Häkkinen, National Institute for Health and Welfare (THL).
On the State of the Art in Costing Methods Workshop.
21 – 22 January 2015 Edmonton, Alberta Economic surveillance and economic assessments are important sources of information to help administrators and policy makers to track current trends and evaluate policies and care patterns. The Institute of Health Economics, in partnership with Alberta Health, held a two-day Costing Methods Workshop which helped to review costing practices…
Biographies Workshop MC Mr. Don Husereau Don Husereau is a Senior Associate with the Institute of Health Economics. He is also an Adjunct Professor of Medicine at The University of Ottawa and a Senior Scientist at the University for Health Sciences, Medical Informatics and Technology in Hall in Tirol, Austria. Between 2001 and 2011, he worked for the Canadian Agency for Drugs and…
Weds 21 Jan 2015 | Thurs 22 Jan 2015 On the State of the Art in Costing Methods: Workshop - Final Program Download Compressed Folder Containing All Presentations (15.2 MB) Wednesday, 21 January 2015 08:30 – 08:45 Introduction to the workshop 08:45 – 10:15 Session One Acute care: Case mix, RIW, CPWCMr. Anyk Glussich, CIHI MIS patient costingMr. Anyk Glussich, CIHIDownload…
Summary Report
On the State of the Art in Costing Methods – Summary ReportDownload Report
Program
On the State of the Art in Costing Methods: Workshop – ProgramDownload Program
Economic surveillance and economic assessments are important sources of information to help administrators and policy makers to track current trends and evaluate policies and care patterns. The Institute of Health Economics, in partnership with Alberta Health, held a two-day Costing Methods Workshop which helped to review costing practices by bringing together economists and other…
PDF of a PowerPoint Presentation by Ms. Karen Lee, Canadian Agency for Drugs and Technologies in Health (CADTH).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mr. Michael Stewart, Ontario Ministry of Health and Long-Term Care (MOHLTC).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mr. Anyk Glussich, Program Lead, Canadian Patient Cost Database (CPCD); Canadian Institute for Health Information (CIHI).
On the State of the Art in Costing Methods Workshop.
| Lindsay Wodinski, Kate Woodman, Margaret Wanke, Thanh Nguyen, Philip Jacobs
Abstract: Alberta's Primary Care Networks (PCNs) bring together family physicians and other health professionals to provide local, comprehensive, and readily accessible primary care services to patients. The Edmonton North PCN, one of the largest in the province, piloted the Resource in Clinic (RIC) Program with objectives to increase efficiencies in the use of physician…
Primary Care Low Back Exam factsheet - 2006.
Extracted from the Chronic Pain Management Binder November 2005.
Link to Alberta Ambassador Guideline Adaptation Program
This consensus development conference was commissioned by the Government of Alberta to improve the transition of its system of care for people with severe and persistent mental illness (SPMI) toward the community. The system, previously hospital- and institution-centred, is moving towards becoming a community-centred, patient- and family-led one. The development and deployment…
À titre de président du jury, le Dr Alain Lesage, M.D., FRCPC, M.Phil., DFAPA, professeur au département de psychiatrie de l'Université de Montréal et clinicien à l’Institut universitaire en santé mentale de Montréal, Québec, a dirigé un comité spécial dont le mandat était d'élaborer…
Clinical Resources | Patient Resources Clinical Practice Guideline Primary Care Management of Headache in Adults (2nd edition September 2016) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttps://actt.albertadoctors.org/CPGs/Pages/Headache.aspx Supporting Documents and Process Description Background Document, 2nd Edition.Download…
Clinical Resources | Patient Resources Clinical Practice Guideline Evidence-Informed Primary Care Management of Low Back Pain(3rd edition, December 2015; minor revision July 2017) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttps://actt.albertadoctors.org/CPGs/Pages/Low-Back-Pain.aspx Supporting Documents and Process Description…
| Caroline Sheppard, Erica Lester, Anderson Chuck, David Kim, Shahzeer Karmali, Christopher Gara, Daniel Birch
INTRODUCTION: The objective of this study was to determine the short-term cost impact thatmedical tourism for bariatric surgery has on a public healthcare system. Due to long wait times for bariatric surgery services, Canadians are venturing to private clinics in other provinces/countries. Postoperative care in this population not only burdens the provincial health system…
Health Economics Unit Health economics is a form of economics-based research that analyzes efficiency, effectiveness, value, and behaviour in the production and consumption of health and health care. Health Economic Services The IHE provides a wide range of economic analyses to inform effective allocation of health resources, including: Economic analyses: cost-effectiveness, cost-utility,…
2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 Roundtables, Workshops, and Conferences are designed and intended to encourage collaboration and facilitate discussion among industry, academic, and government stakeholders. Various IHE events have also been produced in partnership with other organizations, and have seen…
In December 2008, the IHE launched a series of semi-annual innovation forums whose goal is to bring together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system, not just in Alberta, but to all of Canada and the international community, as well. Details of each session are available by selecting the event link below.…
Knowledge Transfer & Dissemination Knowledge transfer and dissemination is an integral part of the IHE’s activities. As a neutral convenor for health policy dialogue and evidence development and dissemination, the IHE has a well-established role in facilitating and supporting the translation of knowledge into practice. Included in the IHE’s knowledge transfer portfolio are numerous…
Health Technology Assessment and Evidence Reviews Health system decision-makers are frequently confronted with decisions about introducing innovative drugs, medical devices, surgical procedures, and processes of care, as well as optimizing the current delivery of care. These technologies and processes are complex, and assessing their value to the health system requires scientific…
Chair Mr. Robert Seidel, KC, Canada Managing Partner, DLA Piper Government and Public Authorities Mr. Andre Tremblay, Deputy Minister, Health Mr. David James, Deputy Minister, Alberta Technology and Innovation Mr. Tim Murphy, Vice President of Health at Alberta Innovates, Alberta Innovates Dr. Peter Jamieson, Interim Vice-President and Chief Medical Officer, Alberta Health Services…
The IHE is frequently requested to be a partner on academic grant applications and policy initiatives with other organizations. In particular we are often the economic analysis partner or knowledge transfer partner for other organizations. Academic University of Alberta http://www.ualberta.ca/ The U of A is a leader in research. Our campuses attract professors with international…
The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…
Speaker Biographies Keynote Speakers Dr. Andreas LaupacisChair, Health Quality Ontario Dr. Laupacis is a general internist and the Executive Director of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor at the University of Toronto in both the Department of Medicine and the Institute of Health Policy, Management and Evaluation. Dr. Laupacis…
27 November 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health WelcomeDr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://vimeo.com/channels/907291/113749308 Greetings from the ProvinceGlenn Monteith, Chief Delivery Officer, Alberta Healthhttp://vimeo.com/channels/907291/113749310 Keynote presentations Health System Standards: From Good Intent to…
27 November 2014 Edmonton, Alberta Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XII – Health System Standards: From Good Intent to Real World…
Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Upcoming Events Information on upcoming events hosted by the Institute of Health Economics (IHE) as well as upcoming events hosted by national and international health economics organizations and associations. The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose,…
Creating Value Through Collaboration The Institute of Health Economics (IHE) is an independent, not-for-profit organization with key competencies in health economics, health technology assessment, and knowledge transfer/exchange. Our mission is to consistently provide relevant, timely and impactful evidence that supports informed health system policy and investment decisions…
Our History The Institute of Health Economics (IHE), formerly the Institute of Pharmaco-Economics, was founded in 1995 on the belief that the best solutions to healthcare problems are the result of a collaborative approach, with all stakeholders at the table sharing insights and information. First led by the Rt. Hon. Don Mazankowski (Board Chair) and Dr. Devidas Menon (CEO), the…
Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference 23 November 2014 Edmonton, Alberta This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the…
PDF of a PowerPoint Presentation by Dr. Ken Butcher, WMC Health Sciences Centre, University of Alberta. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference In this 45 minute presentation, Dr. Butcher reviewed how to diagnose stroke and discussed the burden of Cardioembolic and Cryptogenic Stroke. He talked about the recent…
PDF of a PowerPoint Presentation by Dr. Thomas Jeerakathil, Associate Professor, University of Alberta; Co-physician lead, ASPIRE TIA Triaging Project, Northern Stroke Lead CV/S SCN. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference This presentation looked at the diagnosis of likely TIA syndromes and how to identify and…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the continuously advancing field of stroke prevention and care, with a particular focus on the role of primary care. The forum was…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
17 November 2014 Ottawa, Ontario The federal Ministry of Health (Health Canada) announced the creation of the Advisory Panel on Healthcare Innovation on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s directive is to determine what approaches hold the greatest potential for Canadians and to create…
Monday, 17 November 2014 Ottawa, Ontario Opening and Opening Remarks Moderator: Mr. John Sproule, IHE Ms. Lauren Fisher, Eli Lilly Canada Inc. Mr. Glenn Brimacombe, Canadian Psyciatric Association Roundtable Discussion: What can the federal government do to promote and support innovation in the healthcare system? Overview of current state of healthcare innovation from a Federal…
Summary Report
Health Innovation in Canada: Federal Role Roundtable: Summary ReportDownload Report
Background Document
Health Innovation in Canada: Federal Role Roundtable – BackgrounderDownload Background Document
The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…
Objectives: To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex.
| Victoria Ung, Thanh Nguyen, Karen Wong, Karen Kroeker, Thomas Lee, Haili Wang, Arto Ohinmaa, Philip Jacobs, Richard Fedorak
BACKGROUND & AIMS: Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs infliximab and response rates derived from early clinical trials. In real life, therapeutic options are more complex; patients…
Speakers | Jury | Scientific Committee | Planning Committee Scientific Chair Roger Bland, CM, MB, ChB, FRCPC, FRCPsych Chair, Scientific Committee; Professor Emeritus, Department of Psychiatry, University of Alberta, Edmonton, Alberta Speakers Carol Adair, MSc, PhD Researcher, Psychiatric Epidemiologist and Associate Professor, Departments of Psychiatry and of Community…
Program Consensus Development Conference on Improving Mental Health Transitions 2014 - Final ProgramDownload Program Consensus Statement Consensus Statement on Improving Mental Health Transitions 2014Download Consensus Statement Déclaration de consensus sur l'amélioration des transitions en santé mentaleTélécharger la déclaration de consensus Media Release 6 November 2014 – Consensus…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Tues 4 Nov 2014 | Wed 5 Nov 2014 | Thu 6 Nov 2014 Improving Mental Health Transitions 2014 - Final Program Tuesday, 4 November 2014 08:00 – 08:45 Opening RemarksRoger Bland, CM, MB, ChB, FRCPC, FRCPsychhttp://vimeo.com/channels/839914/112193615 GreetingsCouncillor Scott McKeenhttp://vimeo.com/112193618 Opening Prayer from ElderGloria Lairdhttp://vimeo.com/112193614 Improving Mental…
The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS) hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 - 6, 2014.
PDF of a PowerPoint presentation by Dr. Philippa Garety, MA, MPhil, MA (Ed), PhD, FBPsS.
Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Roger Bland, CM, MB, ChB, FRCPC, FRCPsych.
Consensus Development Conference on Improving Mental Health Transitions
2 November 2014 Toronto, Ontario In April 2014, we held the first roundtable discussion on the current and future role of real world evidence (RWE) in Canada, bringing together multiple stakeholders from across Canada and internationally. Workshop participants felt there was much more to explore in future discussion and a specific need was identified to focus part of future conversations…
Biographies Chris Henshall Health Economics Research Group (HERG), Brunel University Dr. Chris Henshall is an Honorary Professor at HERG and an independent consultant on health, research and innovation policy. Chris has held various academic and senior management positions in the health research system and the higher education system in the UK. He is an Associate Professor in the…
Sunday, 2 November 2014 Toronto, Ontario Opening and Opening Remarks John Sproule, IHE Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU PART I: Fit for purpose: When and where is real-world evidence most useful? Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's…
Roundtable Final Report
Roundtable on Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report – September 2014Download Roundtable Final Report
Program
Real World Evidence: Priority Setting for Action – How to best use health system data to improve health?Download Program
Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support Unit (Ontario) and AstraZeneca Canada. It was held in conjunction with the annual Canadian Association for Population Therapeutics (CAPT).…
Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…
PDF of a PowerPoint presentation by Dr. Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital.
Real World Evidence: Priority Setting for Action Roundtable
PDF of a PowerPoint presentation by Mr. Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan.
Real World Evidence: Priority Setting for Action Roundtable
| Don Husereau, Anthony Culyer, Peter Neumann, Philip Jacobs
Abstract: Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and…
Published quarterly by the KRP Tax Group, our newsletter provides up-to-date information regarding the latest tax rules and accounting principles. To subscribe to our electronic newsletter, please fill out the form below:
Privacy Statement The Institute of Health Economics values your privacy. This Privacy Statement of the Institute of Health Economics (IHE), 1200 – 10405 Jasper Avenue NW, Edmonton, Alberta T5J 3N4 ("IHE" "we" "us" or "our") outlines how your personally identifiable information and other data relating to you (your "personal data") will be collected, used, and shared in connection…
Media Inquiries John Sproule, Senior Policy Director Email: [email protected] Phone: 780-862-1905. General Inquiries The Institute of Health Economics welcomes your inquiries. If you wish to receive more information about any of our products or services, please either use the form below or contact us at the address listed below. Institute of Health Economics 1200, 10405 Jasper…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…
| Arto Ohinmaa, Thanh Nguyen, Cheryl Barnabe, Liam Martin, Anthony Russell, Susan G Barr, Walter Maksymowych
OBJECTIVE: To provide Canadian estimates of health care utilization costs associated withrheumatoid arthritis (RA)-related and non-RA-related care within 4 treatment strategies and in different physical functioning categories.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…
| Cheryl Barnabe, Thanh Nguyen, Arto Ohinmaa, Joanne Homik, Susan G Barr, Liam Martin, Walter Maksymowych
OBJECTIVE: Sustained remission in rheumatoid arthritis (RA) results in healthcare utilizationcost savings. We evaluated the variation in estimates of savings when different definitions ofremission [2011 American College of Rheumatology/European League Against Rheumatism Boolean Definition, Simplified Disease Activity Index (SDAI) ≤ 3.3, Clinical Disease Activity Index…
| Carolyn Dewa, Desmond Loong, Sarah Bonato, Thanh Nguyen, Philip Jacobs
BACKGROUND: Interest in the well-being of physicians has increased because of their contributions to the healthcare system quality. There is growing recognition that physicians are exposed to workplace factors that increase the risk of work stress. Long-term exposure to high work stress can result in burnout. Reports from around the world suggest that about one-third to…
Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…
| Don Husereau, Philip Jacobs, Braden Manns, Ties Hoomans, Deborah Marshall, Robyn Tamblyn
This discussion paper has been produced in response to a request from CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper will provide guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation, and serve as…
Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…
PDF of a PowerPoint presentation by Dr. Elizabeth Bryce, BSc, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Daniel Gregson, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Lindsay Nicolle, BSc, BSc (med), MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Anthony Harris, MD, MPH.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Ms. Kim Neudorf.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Yves Longtin, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Trish Perl, MD, MSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Eli Perencevich, MD, MS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Mark Loeb, BSc, MSc, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Serge Desnoyers, PhD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
18 – 20 June 2014 Calgary, Alberta The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 – 20, 2014, was the first event of its kind to look at issues in the field of AROs. Download Consensus Statement The Consensus Conference model is an exciting format, geared to creating…
Speakers | Jury | Scientific Committee | Organizing Committee Speakers Elizabeth Bryce, BSc, MD, FRCPCRegional Medical Director for Infection Control, Vancouver Coastal Health; Clinical Professor, University of British Columbia (UBC) Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPathProfessor, University College and London School…
Weds 18 June 2014 | Thurs 19 June 2014 | Fri 20 June 2014 Surveillance and Screening for Antimicrobial Resistant Organisms (AROs) 2014 - Final Program Wednesday, 18 June 2014 08:00 – 08:15 Opening RemarksDr. John Conly and Dr. James Talbothttp://vimeo.com/channels/910470/99417520 08:15 – 09:45 QUESTION 1: Overview a) What are AROs? What is their incidence…
Program Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) 2014 – Final ProgramDownload Program Consensus Statement Consensus Statement on Surveillance and Screening of AROs (Antimicrobial-Resistant Organisms)Download Consensus Statement Remarks from Jury Chair Remarks from the jury chair, Dr. Tom Marrie, Dean of…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
PDF of a PowerPoint presentation by Dr. Pilar Ramon-Pardo, MD, PhD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Howard Njoo, MD, MHSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Julian Davies, BSc, PhD, FRS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Scott McEwen, DVM, DVSc, Dip ACVP.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Joel Kettner, MD, MSc, FRCSC, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Andrew Simor, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Robert Weinstein, MD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. James Talbot, PhD, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. David Patrick, MD, FRCPC, MHSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Michael Edmond, MD, MPH, MPA.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Henri Verbrugh, MD, PhD, FIDSA.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Allison McGeer, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Susan Huang, MD, MPH.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. John Jernigan, MD, MS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 - 20, 2014, was the first event of its kind to look at issues in the field of AROs.
| Carolyn Dewa, Philip Jacobs, Thanh Nguyen, Desmond Loong
BACKGROUND: Interest in the impact of burnout on physicians has been growing because of the possible burden this may have on health care systems. The objective of this study is toestimate the cost of burnout on early retirement and reduction in clinical hours of practicingphysicians in Canada.
The objective of this paper is to estimate the additional costs to the criminal justice system associated with people with mental illness who go through the system. The focus of the report is on costs in Alberta.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…
Thursday, 29 May 2014 Edmonton, Alberta The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Key Symposium Documents Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program Rheumatoid Arthritis…
Speaker Biographies Dianne Mosher, MD Dr. Dianne Mosher is currently Professor of Medicine and the Chief of the Division of Rheumatology at the University of Calgary. She has practiced Rheumatology for the past twenty years having graduated from Dalhousie Medical School in 1983 where she also completed her Internal Medicine and Rheumatology residency training. Dr. Mosher is a past…
Thursday, 29 May 2014 Edmonton, Alberta Moderator Dianne Mosher, University of Calgary 09:00 – 09:15 Welcome and Opening Remarks Michele Evans, Executive Director, Pharmaceutical Funding and Guidance, Government of Albertahttp://vimeo.com/album/3477664/video/97379108 09:15 – 09:30 Biologic and Biosimilar Therapies - The Changing Landscape of the Management of Rheumatoid…
Symposium Program
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program
White Paper
Rheumatoid Arthritis in a Policy Perspective: A registry for research and better treatment of Albertans – White PaperDownload White Paper
PDF of PowerPoint Presentation by Dr. Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Liam Martin, Professor, University of Calgary.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Suzanne Lepage, Private Health Plan Strategist.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium Note: Slide 16 of this presentation contains an error…
PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
Speaker Biographies Keynote Speakers Dr. Sube Banerjee MB BS, MSc, MBA, MD, FRC Psych, MBEProfessor & Associate Dean, Brighton and Sussex Medical School Sube Banerjee is Professor of Dementia and Associate Dean for Strategy at Brighton and Sussex Medical School, directing its Centre for Dementia Studies. Clinically he works as an old age psychiatrist in Sussex. He was the Department…
27 May 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/97426151 Keynote presentations Quality of life and quality of care in dementiaDr. Sube Banerjee, Brighton and Sussex Medical SchoolDownload Presentation http://vimeo.com/channels/907291/97466183 Coordinating Care…
27 May 2014 Edmonton, Alberta Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care – FINAL PROGRAMDownload…
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Sube Banerjee, Brighton and Sussex Medical School.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Duncan Robertson, Seniors Health Strategic Clinical Network, Alberta Health Services.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Carole Estabrooks, University of Alberta.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. David C. Grabowski, Harvard Medical School.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
This informative PowerPoint is publicly available for use as an introductory resource for justice professionals who are seeking an educational tool to assist in group presentations/training regarding involvement of those with Fetal Alcohol Spectrum Disorder (FASD) in the criminal justice system.
Le PowerPoint informative est publiquement disponible pour une utilisation en tant que ressource d'introduction pour les professionnels de la justice qui cherchent un outil pédagogique pour aider à des présentations de groupe / formation concernant la participation de ceux qui ont des troubles causés par l'alcoolisation fœtale (ETCAF ) dans le…
Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors. OBJECTIVE: The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on…
OBJECTIVES: The objective of this study was to explore the degree to which databases otherthan MEDLINE contribute studies relevant for inclusion in rapid health technology assessments (HTA).
This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
| Lianne Barnieh, Braden Manns, Anthony Harris, Marja Blom, Cam Donaldson, Scott Klarenbach, Don Husereau, Diane Lorenzetti, Fiona Clement
BACKGROUND: The use of a restrictive formulary, with placement determined through a drug-reimbursement decision-making process, is one approach to managing drug expenditures.
IHE In Your Pocket 2014 – a handbook of health economic statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…
| Sherilyn Houle, Finlay McAlister, Cynthia Jackevicius, Anderson Chuck, Ross Tsuyuki
BACKGROUND: Pay-for-performance (P4P) is increasingly touted as a means to improve health care quality.
PURPOSE: To evaluate the effect of P4P remuneration targeting individual health careproviders.
Speaker Biographies Keynote Speaker Mr. Don DrummondFormer Senior Vice President and Chief Economist, TD Bank Financial Group Don Drummond is the former Senior Vice President and Chief Economist at TD Financial Group. He retired from TD to his current role as Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University. Prior to joining…
6 December 2012Edmonton, Alberta Introductory Remarks – Government of Alberta Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/56013748 Keynote Presentation Mr. Don Drummond, Former Senior Vice President and Chief Economist, TD Bank Financial Grouphttp://vimeo.com/channels/907291/56036522 Panel Discussion ModeratorDr. Annette Trimbee,…
6 December 2012 Edmonton, Alberta Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report performs an evaluation of the scientific evidence on the safety, performance, and effectiveness of universal and targeted preschool hearing screening (PHS) to inform the Infant and Preschool Screening Framework being developed by the Community and Public Health (CPH)…
Stroke Prevention and Management in Primary Care: a free forum at the 2012 Accelerating Primary Care Conference Sunday, 18 November 2012 Fairmont Banff Springs Hotel, Banff, Alberta Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together…
Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together 5 physician leaders to review the current “state of the art” in the rapidly advancing field of stroke prevention and care, with an emphasis on the role of primary care.…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This review focused on the best evidence available on the use of PSVS to detect vision conditions in asymptomatic preschool children (aged from birth to 6 years; not necessarily considered at risk for developing visual impairment) to determine the safety and efficacy/effectiveness…
The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in Alberta was recognized in eary 2012, colleagues…
18 – 19 October 2012 Canmore, Alberta The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in Alberta…
Biographies Stirling Bryan National Institute for Health and Clinical Excellence (NICE) Experience with Using the EQ-5D in Economic Analysis Dr. Stirling Bryan is a professor in UBC's School of Population & Public Health, and Director of the Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute. Dr. Bryan is an economist with a career-long specialization…
Thurs 18 Oct 2012 | Fri 19 Oct 2012 Thursday, 18 October 2012 08:45 – 09:00 Welcome and Opening Remarks Charlene McBrien-Morrison, Executive Director, Health Quality Council of Alberta Steve Buick, Director of Policy and Communications, Institute of Health Economics Kathryn Todd, Senior Vice President, Research, Alberta Health Services 09:00 – 09:30 EQ-5D - Building Common Understanding…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as…
This project is concerned with describing a comprehensive set of HTA products, not the methods used to produce them. The report describes various products produced by HTA agencies and provides a summary of the basic elements of these products, but an in-depth analysis of, or comparison between, the various products in terms of their methodology is beyond its scope. Information…
Background: The aim of this study was to extend an earlier retrospective cohort study of schizophrenia via a prospective study to a follow-up of 34 years, with an emphasis on describing the life-course of the illness.
| Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs
Background: The benefits of pharmaceutical innovations are widely diffused; they accrue to the healthcare providers, patients, employers, and manufacturers. We estimate the societal monetary benefits of simvastatin in Canada and its distribution among different beneficiaries overtime.
| Mel Slomp, Philip Jacobs, Arto Ohinmaa, Roger Bland, Ray Block, Carolyn Dewa, Carina Wang
OBJECTIVES: In Canada, most mental health services are embedded in the publichealth care system. Little is known of the cost distribution within the mental healthpopulation. Our study aims to estimate the depression care costs of patients with adepression diagnosis, ranking them by the increasing total depression health carecosts.
| Logan McLeod, JoAnn Kingston-Riechers, Egon Jonsson
Abstract: The potential risks to patient safety in a primary care setting are different than the risks to patient safety in an acute care setting. The main differences arise from the organisational structures of primary care delivery and the greater involvement of patients in their care. To account for these differences, we present the Patient Safety in Primary Care Framework…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an epidemiological profile of fetal aneuploidy and open neural tube defects (ONTD); describes the patterns of care, utilization trends, and factors affecting the provision of first and second trimester screening (FASTs) services for fetal aneuploidy and…
30 July 2012 Montréal, Québec The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized…
Monday, 30 July 2012Montréal, Québec Welcome, Introductions, and Overview John Sproule, IHEDon Husereau, University of Ottawa Roundtable Discussion – Assessment of System Readiness Moderator: John Sproule Is the current state of adoption and implementation ideal? What should the goals be for personalized medicine in Canada? What are the components of a vision…
This background document outlines the methods used to update the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program.
Link to Alberta Ambassador Guideline Adaptation Program
For which strategies of suicide prevention is there evidence of effectiveness? This report aims to synthesize research findings from existing systematic reviews to address two questions: What types of preventive interventions have been evaluated in the published literature? Which strategies have good-quality evidence to support them? Limited evidence - as well as variability by…
The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized medicine promises to increasingly change the…
Primary Care Management of Headache in Adults1st edition, July 2012Guideline Documents including Full Guideline (Hosted by Towards Optimized Practice (TOP) Alberta)
The guideline was developed as part of the Alberta Ambassador Guideline Adaptation Program (http://www.ihe.ca/research-programs/hta/aagap)
| Sherilyn Houle, Anderson Chuck, Finlay McAlister, Ross Tsuyuki
STUDY OBJECTIVE: To quantify the potential cost savings of a community pharmacy-basedhypertension management program based on the results of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN) study in terms of avoided cardiovascular events-myocardial infarction, stroke, and heart failure hospitalization, and to compare these cost savings…
31 May 2012 Edmonton, Alberta
Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Key Forum Documents
Innovation Forum VII – Social Determinants of Health – FINAL PROGRAMDownload Final Program
Speaker Biographies Keynote Speaker Sir Michael MarmotDirector, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London Sir Michael Marmot has led a research group on health inequalities for the past 30 years. He has been invited by the Regional Director of WHO Euro to conduct a European review of health inequalities. At the request of the…
31 May 2012Edmonton, Alberta Welcome and Introductions Dr. Lorne Tyrrell, Chair, Institute of Health EconomicsDownload Presentation http://vimeo.com/channels/907291/44105094 Dr. Chris Mazurkewich, Executive Vice President and CEO, Alberta Health Serviceshttp://vimeo.com/channels/907291/45175125 Honourable David Hancock, Minister of Human Serviceshttp://vimeo.com/channels/907291/44087423 …
PDF of a PowerPoint presentation by Sir Michael Marmot, Director, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London.
IHE Innovation Forum VII – Social Determinants of Health
Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
| Bach Tran, Arto Ohinmaa, Anh Duong, Nhan Do, Long Nguyen, Quoc Nguyen, Steve Mills, Philip Jacobs, Stan Houston
PURPOSE: This longitudinal study assessed the changes in drug use patterns and health-related quality of life (HRQL) among HIV-positive drug users in the first methadonemaintenance treatment (MMT) cohort in Vietnam.
| Paula Corabian, Dagmara Chojecki, Christa Harstall
This exploratory report provides a summary of some of the published information on the current status of research in and potential future sphere of activity of nanomedicine (Part I) and an inventory of resources on nanotechnology and nanomedicine (Part II). Over the next 5 to 10 years it is expected that the overall impact of nanomedicine will be multifaceted, with significant…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report summarizes available key information on the use of bariatric treatments for adult obesity in Alberta and North America (mainly Canada). This analysis was intended to describe the profile of adult obesity (definition, progression, epidemiology, and population dynamics…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the research evidence on the safety and efficacy of insulin pump therapy, as compared to multiple daily insulin injections, in the treatment of children, adults, and pregnant women diagnosed with type 1 diabetes. The report also analyses the economic impact…
| Carmen Moga, Bing Guo, Don Schopflocher, Christa Harstall
This Methodology Paper summarizes the process, a modified Delphi approach, used to develop a specific checklist for the quality appraisal of case series studies. This work was supplemented with a review of other published checklists and an initial pilot test of the newly developed quality appraisal checklist. Researchers at the Institute of Health Economics with researchers from…
| Anne-Marie Boström, Susan E Slaughter, Dagmara Chojecki, Carole Estabrooks
OBJECTIVES: The recent emphasis on knowledge translation (KT) in health care is based on the premise that quality of care improves when research findings are translated into practice. This study aimed to identify the extent, nature, and settings of KT research pertaining to the care of older adults.
This report describes a framework for evaluating policies developed within the Alberta Health Technologies Decision Process (AHTDP) to strengthen the link between policy development and evidence. The framework was designed as a foundation upon which to build a more detailed and contextualized evaluative process in consultation with all stakeholders who are likely to be affected…
In February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly undertake with its data or with data that could be easily obtained. The purpose of this report…
Sponsored by the Institute of Health Economics (IHE) – Methodology Forum Series. Presented at the Health Canada and Canadian Institutes of Health Research Personalised Medicine in Canada: A Multi-Stakeholder Workshop to Examine the Canadian Perspective, January 12, 2012. The specific objectives of this session/workshop were to: Explore issues relevant to economic evaluation…
| Bing Guo, Christa Harstall, Thomas Louie, Sander Veldhuyzen van Zanten, Levinus Dieleman
Aim: To critically appraise the clinical research evidence on the safety and effectiveness of FT compared with standard care in the treatment of patients with CDAD.
6 – 7 February 2012 Edmonton, Alberta As part of the Alberta Ambassador Guideline Adaptation Program, in February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly…
From the Introduction: Until four or five decades ago, the clinical consensus about childhood depression was that it did not, and perhaps could not, occur (Lefkowitz & Burton, 1978; Rie, 1966; Rochlin, 1965; Wolfenstein, 1966). In fact, prior to 1960, childhood depression was rarely mentioned in the literature (Cytryn, 2003; Tisher, 2007). A number of studies and conceptualizations…
11 – 12 January 2012 Ottawa, Ontario The IHE has established a series of methodologic forums with the intent of identifying and addressing major methodological challenges in informing policies and decisions around the funding and use of health technologies, in partnership with its private and public stakeholders that are involved in the production of evidence and use of assessment.…
Speakers Dr. Jeffrey Hoch Associate Professor, Department of Health Policy, Management and Evaluation, University of Toronto; Director Pharmacoeconomics Research Unit, Cancer Care Ontario Dr. Stuart Peacock Associate Professor, School of Population and Public Health, University of British Columbia; Co-Director, Canadian Centre for Applied Research in Cancer Control Mr. Don Husereau…
Wednesday – Thursday, 11 – 12 January 2012Ottawa, Ontario Selected Plenary Presentations from Health Canada/CIHR Workshop Measuring Value in Personalized MedicineDr. Deborah Marshallhttp://player.vimeo.com/video/35735037 HTA Assessment in Australia - Challenges for Personalized MedicineDr. Robyn Wardhttp://player.vimeo.com/video/35785570 Stratified Medicine - Observations…
| Carissa Escober-Doran, Philip Jacobs, Carolyn Dewa
This study measures the return on investment for parent training at the pre- or early childhood stage. The purpose is to prevent conduct disorders in childhood, and mental health problems in adolescence and adulthood. The program studied is the Triple P program. The context is a one year birth cohort in Alberta. The costs are for a universal parental training program. The downstream…
| Maureen Yunkap Kwankam, David Hailey, Philip Jacobs
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #13. This assessment has been prepared in view of the interest at the University of Alberta Hospital in developing a cord blood banking facility in the province and to provide information to decision makers on the current status of cord blood transplantation (CBT). The principal purpose of the assessment was to…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #12. This report has been prepared following a request from the provincial Clinical Practice Guidelines Program for information on the accuracy of diagnostic tests for the detection of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis in females of reproductive age. The intention of this…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #11. This report has been prepared in view of the increasing interest in ultrasound technology for diagnosis of osteoporosis. Until recently, quantitative ultrasound (QUS) was mainly being used in research settings. This procedure is still not covered by provincial fee schedules. The recent FDA pre-marketing approvals…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #10. This report has been prepared as part of a project to assess the role of high cost functional diagnostic imaging (FDI) and related methods in routine health care. In the present paper, the potential application of four FDI methods to the management of epilepsy is considered. The assessment considered the current…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #8. This report has been prepared to provide information to health authorities and others on the available evidence on effectiveness of HBOT and the possible economic impact on health care should a second HBO facility be established in the province. Issues addressed in the report include: Whether HBOT has been…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #9. The present report has been prepared following a request by Alberta Health in relation to referral of patients outside the province for treatment with stereotactic radiosurgery (SRS). There was interest by the department in the comparative effectiveness of the two main approaches to SRS (GK and LINAC) and in…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #7. This assessment was undertaken at the request of a Regional Health Authority to provide input into a funding decision on a computerized dynamic posturography (CDP) system for use by a rehabilitation department. The focus of this study was restricted to the clinical use of CDP by the rehabilitation community.…